UC's custom 3D-printed skull implants go global
December 13, 2019
Unable to get image from page properties or content. Will fall back to a default image.
Article has no nextliveshere tags assigned
Article has no topics tags assigned
Article has no colleges tags assigned
Article has no audiences tags assigned
Article has no units tags assigned
Contacts are empty
These messages will display in edit mode only.
Pilot grants totaling $175,000 were recently awarded to University of Cincinnati (UC) researchers to fund projects dedicated to advancing science and finding new therapies for pancreatic and head and neck cancers.
GIVEHOPE Pancreatic Cancer Research and Awareness Fund:
$47,500 to Xiaoyang Qi, PhD, professor in the Division of Hematology Oncology, member of the Cincinnati Cancer Center and UC Cancer Institute. Qi and his team will study a cellular structure and function in metastatic pancreatic cancer cells and determine the therapeutic efficacy of nanovesicles by blocking certain cancer-causing pathways in cancer development and spread.
$47,500 to Fukun Guo, PhD, associate professor in the Department of Pediatrics and a researcher at Cincinnati Children’s. Guo and his team will determine the efficacy of chemical targeting of animal and human regulatory T cells (a type of white blood cells) as a way to trigger immunity against pancreatic tumor formation.
Steven Goldman Memorial Pancreatic Cancer Research Grant:
$55,000 to Yana Zavros, PhD, professor in the Department of Pharmacology and Systems Physiology, and her team. As Zavros received funds from the Goldman grant last year, her continuing project will focus on putting individual pancreatic cancer patient immune cells into an organoid culture to predict the best treatment for that person. An organoid is a three-dimensional, multicellular miniaturized version of the tissue or organ from which it was derived. The hope is that this personalized assessment will improve outcomes for patients.
Brandon C. Gromada Head and Neck Cancer Foundation Research Fund:
$25,000 to Vinita Takiar, MD, PhD, assistant professor in the Department of Radiation Oncology and member of the UC Cancer Institute, and her multidisciplinary team including medical oncologist Trisha Wise-Draper, MD, surgeon Alice Tang, MD, and post-doctoral fellow Christina Wicker, PhD. Their project will collect pilot data for a new approach to treatment of head and neck cancers by looking first at patient-derived organoids. Growing tumors in the lab directly from patients will provide the researchers with a new way to study head and neck cancers and test treatment options.
December 13, 2019
December 13, 2019
December 12, 2019
Angela Clark and her research team started noticing an unprecedented trend — an increasing number of people who needed emergency services after receiving naloxone (Narcan), an opioid antagonist used for complete or partial reversal of opioid overdose. The overdose victims were arriving outside the emergency department, which meant nurses were walking outside the emergency department to aid these incapacitated patients. Clark knew nurses had not been trained to respond to these situations, and their safety was at risk. Angela Clark, a professor of nursing at the University of Cincinnati, decided to develop a training program to teach nurses how to protect themselves while leveraging their medical expertise. “Nurses are trained to put the patient first, while police are trained to put safety first,” said Clark, whose team launched the Be-SAFE program in 2017.